Source comparison
Tesamorelin/Ipamorelin vs. CJC-1295/Ipamorelin: A Quick Comparison
Since many researchers consider both Tesamorelin and CJC-1295 (No DAC) for the GHRH component of their stack, it's helpful to see them side-by-side. The choice often depends on the specific aims of the study. Primary Mechanism GHRH Analogue Half-Life Approxima
This comparison does not assign a generated winner or score.
- Since many researchers consider both Tesamorelin and CJC-1295 (No DAC) for the GHRH component of their stack, it's helpful to see them side-by-side. The choice often depends on the specific aims of the study.
- Primary Mechanism
- GHRH Analogue
- Half-Life
- Approximately 25-40 minutes
- Approximately 30 minutes
- Primary Research Focus
- Strong clinical data on visceral fat reduction
- General GH elevation, anti-aging research
- Specificity
- High specificity for GHRH receptors
- Key Differentiator
- More extensive body of clinical research
- Often cited for a very clean, sharp GH pulse
- Our experience shows that labs focused on metabolic studies, particularly those involving adipose tissue, often gravitate towards Tesamorelin due to the wealth of existing data. Labs conducting broader anti-aging or recovery-focused research might opt for CJC-1295/Ipamorelin. Both are valid tools. The key is to Find the Right Peptide Tools for Your Lab based on a clearly defined research question.